Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas
Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas |
https://doi.org/10.18632/oncotarget.27834
Syed M. Faisal,
Flor M. Mendez,
Fernando Nunez,
Maria G. Castro,
and Pedro R. Lowenstein
|
4607-4612 |
Inorganic polyphosphate as an energy source in tumorigenesis
Inorganic polyphosphate as an energy source in tumorigenesis |
https://doi.org/10.18632/oncotarget.27838
Jerusha Boyineni,
Simone T. Sredni,
Naira V. Margaryan,
Lusine Demirkhanyan,
Michael Tye,
Robert Johnson,
Fernando Gonzalez-Nilo,
Mary J.C. Hendrix,
Evgeny Pavlov,
Marcelo B. Soares,
Eleonora Zakharian,
and Sergey Malchenko
|
4613-4624 |
Identification of nuclear export signal in KLLN suggests potential role in proteasomal degradation in cancer cells
Identification of nuclear export signal in KLLN suggests potential role in proteasomal degradation in cancer cells |
https://doi.org/10.18632/oncotarget.27833
Madhav Sankunny,
and Charis Eng
|
4625-4636 |
Inhibitors of cytoskeletal dynamics in malignant mesothelioma
Inhibitors of cytoskeletal dynamics in malignant mesothelioma |
https://doi.org/10.18632/oncotarget.27843
Katarina Reis,
Jack L. Arbiser,
Anders Hjerpe,
Katalin Dobra,
and Pontus Aspenström
|
4637-4647 |
Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study
Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study |
https://doi.org/10.18632/oncotarget.27837
Pascale Tomasini,
Fabrice Barlesi,
Sophie Gilles,
Isabelle Nanni-Metellus,
Riccardo Soffietti,
Emilie Denicolai,
Eric Pellegrino,
Emilie Bialecki,
L’Houcine Ouafik,
and Philippe Metellus
|
4648-4654 |
Estrogen receptor α polymorphism is associated with dementia in a Brazilian cohort
Estrogen receptor α polymorphism is associated with dementia in a Brazilian cohort |
https://doi.org/10.18632/oncotarget.27744
Rafaella Papalino Lopes Magnago,
Valerio Garrone Barauna,
Bruna Ferro Brun,
Ana Cristina Lo Prete,
Aline Morgan Alvarenga,
Luciene C. Gastalho Campos,
Neuza Felix Gomes Rochette,
Letícia Batista Azevedo Rangel,
Rodrigo Alves Faria,
Paulo Caleb Junior Lima Santos,
and Ian Victor Silva
|
4655-4660 |
Novel 3-(3, 5-difluoro-4-hydroxyphenyl)-1-(naphthalen-2-yl) prop-2-en-1-one as a potent inhibitor of MAP-kinase in HeLa cell lines and anti-angiogenic activity is mediated by HIF-1α in EAC animal model
Novel 3-(3, 5-difluoro-4-hydroxyphenyl)-1-(naphthalen-2-yl) prop-2-en-1-one as a potent inhibitor of MAP-kinase in HeLa cell lines and anti-angiogenic activity is mediated by HIF-1α in EAC animal model |
https://doi.org/10.18632/oncotarget.27836
Dileep Kumar M. Guruswamy,
Kyathegowdana Doddi Srivinavasa Balaji,
Kattepura Krishnappa Dharmappa,
and Shankar Jayarama
|
4661-4676 |